c-Cbl reduces stability of rescued ∆F508-CFTR in human airway epithelial cells

References

• Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245:1066 - 73; http://dx.doi.org/10.1126/science.2475911; PMID: 2475911
   PubMed Web of Science ®Google Scholar
• Rommens JM, Iannuzzi MC, Kerem B, Drumm ML, Melmer G, Dean M, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989; 245:1059 - 65; http://dx.doi.org/10.1126/science.2772657; PMID: 2772657
   PubMed Web of Science ®Google Scholar
• Howard M, Jiang X, Stolz DB, Hill WG, Johnson JA, Watkins SC, et al. Forskolin-induced apical membrane insertion of virally expressed, epitope-tagged CFTR in polarized MDCK cells. Am J Physiol Cell Physiol 2000; 279:C375 - 82; PMID: 10913004
   PubMedGoogle Scholar
• Riordan JR. CFTR function and prospects for therapy. Annu Rev Biochem 2008; 77:701 - 26; http://dx.doi.org/10.1146/annurev.biochem.75.103004.142532; PMID: 18304008
   PubMed Web of Science ®Google Scholar
• Boucher RC. New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Respir J 2004; 23:146 - 58; http://dx.doi.org/10.1183/09031936.03.00057003; PMID: 14738247
   PubMed Web of Science ®Google Scholar
• Tarran R, Button B, Boucher RC. Regulation of normal and cystic fibrosis airway surface liquid volume by phasic shear stress. Annu Rev Physiol 2006; 68:543 - 61; http://dx.doi.org/10.1146/annurev.physiol.68.072304.112754; PMID: 16460283
   PubMed Web of Science ®Google Scholar
• Bertrand CA, Frizzell RA. The role of regulated CFTR trafficking in epithelial secretion. Am J Physiol Cell Physiol 2003; 285:C1 - 18; PMID: 12777252
   PubMed Web of Science ®Google Scholar
• Guggino WB, Stanton BA. New insights into cystic fibrosis: molecular switches that regulate CFTR. Nat Rev Mol Cell Biol 2006; 7:426 - 36; http://dx.doi.org/10.1038/nrm1949; PMID: 16723978
   PubMed Web of Science ®Google Scholar
• Lukacs GL, Segal G, Kartner N, Grinstein S, Zhang F. Constitutive internalization of cystic fibrosis transmembrane conductance regulator occurs via clathrin-dependent endocytosis and is regulated by protein phosphorylation. Biochem J 1997; 328:353 - 61; PMID: 9371688
   PubMed Web of Science ®Google Scholar
• Prince LS, Peter K, Hatton SR, Zaliauskiene L, Cotlin LF, Clancy JP, et al. Efficient endocytosis of the cystic fibrosis transmembrane conductance regulator requires a tyrosine-based signal. J Biol Chem 1999; 274:3602 - 9; http://dx.doi.org/10.1074/jbc.274.6.3602; PMID: 9920908
   PubMed Web of Science ®Google Scholar
• Van Goor F, Hadida S, Grootenhuis PD, Burton B, Stack JH, Straley KS, et al. Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809. Proc Natl Acad Sci U S A 2011; 108:18843 - 8; http://dx.doi.org/10.1073/pnas.1105787108; PMID: 21976485
   PubMed Web of Science ®Google Scholar
• Rogan MP, Stoltz DA, Hornick DB. Cystic fibrosis transmembrane conductance regulator intracellular processing, trafficking, and opportunities for mutation-specific treatment. Chest 2011; 139:1480 - 90; http://dx.doi.org/10.1378/chest.10-2077; PMID: 21652558
   PubMed Web of Science ®Google Scholar
• Lubamba B, Dhooghe B, Noel S, Leal T. Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy. Clin Biochem 2012; 45:1132 - 44; http://dx.doi.org/10.1016/j.clinbiochem.2012.05.034; PMID: 22698459
   PubMed Web of Science ®Google Scholar
• Clancy JP, Rowe SM, Accurso FJ, Aitken ML, Amin RS, Ashlock MA, et al. Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation. Thorax 2012; 67:12 - 8; http://dx.doi.org/10.1136/thoraxjnl-2011-200393; PMID: 21825083
   PubMed Web of Science ®Google Scholar
• Sharma M, Pampinella F, Nemes C, Benharouga M, So J, Du K, et al. Misfolding diverts CFTR from recycling to degradation: quality control at early endosomes. J Cell Biol 2004; 164:923 - 33; http://dx.doi.org/10.1083/jcb.200312018; PMID: 15007060
   PubMed Web of Science ®Google Scholar
• Swiatecka-Urban A, Brown A, Moreau-Marquis S, Renuka J, Coutermarsh B, Barnaby R, et al. The short apical membrane half-life of rescued {Delta}F508-cystic fibrosis transmembrane conductance regulator (CFTR) results from accelerated endocytosis of {Delta}F508-CFTR in polarized human airway epithelial cells. J Biol Chem 2005; 280:36762 - 72; http://dx.doi.org/10.1074/jbc.M508944200; PMID: 16131493
   PubMed Web of Science ®Google Scholar
• Cihil KM, Ellinger P, Fellows A, Stolz DB, Madden DR, Swiatecka-Urban A. Disabled-2 protein facilitates assembly polypeptide-2-independent recruitment of cystic fibrosis transmembrane conductance regulator to endocytic vesicles in polarized human airway epithelial cells. J Biol Chem 2012; 287:15087 - 99; http://dx.doi.org/10.1074/jbc.M112.341875; PMID: 22399289
   PubMed Web of Science ®Google Scholar
• Madden DR, Swiatecka-Urban A. Tissue-specific control of CFTR endocytosis by Dab2: Cargo recruitment as a therapeutic target. Commun Integr Biol 2012; 5:473 - 6; Error! Hyperlink reference not valid http://dx.doi.org/10.4161/cib.21375; PMID: 23181163
   PubMedGoogle Scholar
• Cheng J, Moyer BD, Milewski M, Loffing J, Ikeda M, Mickle JE, et al. A Golgi-associated PDZ domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expression. J Biol Chem 2002; 277:3520 - 9; http://dx.doi.org/10.1074/jbc.M110177200; PMID: 11707463
   PubMed Web of Science ®Google Scholar
• Wolde M, Fellows A, Cheng J, Kivenson A, Coutermarsh B, Talebian L, et al. Targeting CAL as a negative regulator of DeltaF508-CFTR cell-surface expression: an RNA interference and structure-based mutagenetic approach. J Biol Chem 2007; 282:8099 - 109; http://dx.doi.org/10.1074/jbc.M611049200; PMID: 17158866
   PubMed Web of Science ®Google Scholar
• Cushing PR, Vouilleme L, Pellegrini M, Boisguerin P, Madden DR. A stabilizing influence: CAL PDZ inhibition extends the half-life of ΔF508-CFTR. Angew Chem Int Ed Engl 2010; 49:9907 - 11; http://dx.doi.org/10.1002/anie.201005585; PMID: 21105033
   PubMed Web of Science ®Google Scholar
• Roberts KE, Cushing PR, Boisguerin P, Madden DR, Donald BR. Computational design of a PDZ domain peptide inhibitor that rescues CFTR activity. PLoS Comput Biol 2012; 8:e1002477; http://dx.doi.org/10.1371/journal.pcbi.1002477; PMID: 22532795
   PubMedGoogle Scholar
• Ye S, Cihil K, Stolz DB, Pilewski JM, Stanton BA, Swiatecka-Urban A. c-Cbl facilitates endocytosis and lysosomal degradation of cystic fibrosis transmembrane conductance regulator in human airway epithelial cells. J Biol Chem 2010; 285:27008 - 18; http://dx.doi.org/10.1074/jbc.M110.139881; PMID: 20525683
   PubMed Web of Science ®Google Scholar
• Schmidt MH, Dikic I. The Cbl interactome and its functions. Nat Rev Mol Cell Biol 2005; 6:907 - 18; http://dx.doi.org/10.1038/nrm1762; PMID: 16227975
   PubMed Web of Science ®Google Scholar
• Molinski S, Eckford PD, Pasyk S, Ahmadi S, Chin S, Bear CE. Functional rescue of F508del-CFTR using small molecule correctors. Front Pharmacol 2012; 3:160; http://dx.doi.org/10.3389/fphar.2012.00160; PMID: 23055971
   PubMed Web of Science ®Google Scholar
• Vertex Pharmaceuticals. Final data from phase 2 combination study of VX-809 and KALYDECO™ (ivacaftor) showed statistically significant improvements in lung function in people with cystic fibrosis who have two copies of the F508del mutation. 2012; http://investors.vrtx.com/releasedetail.cfm?releaseid=687394.
   Google Scholar
• Hentchel-Franks K, Lozano D, Eubanks-Tarn V, Cobb B, Fan L, Oster R, et al. Activation of airway cl- secretion in human subjects by adenosine. Am J Respir Cell Mol Biol 2004; 31:140 - 6; http://dx.doi.org/10.1165/rcmb.2004-0012OC; PMID: 15039139
   PubMed Web of Science ®Google Scholar
• Denning GM, Anderson MP, Amara JF, Marshall J, Smith AE, Welsh MJ. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 1992; 358:761 - 4; http://dx.doi.org/10.1038/358761a0; PMID: 1380673
   PubMed Web of Science ®Google Scholar